Sign In

Nicole Miller

VP, Molecular Diagnostics at Ultragenyx Pharmaceutical Inc.

Nicole Miller is a seasoned scientist and pharmaceutical/biotechnology professional with over 20 years of experience. She has held leadership roles in Research & Development, Scientific and Molecular Diagnostic Strategy, Newborn Screening, and Medical Affairs, with a strong focus on ensuring timely and accurate diagnosis and treatment of rare diseases. Nicole's expertise lies in Molecular Diagnostics, Scientific Affairs, Medical Affairs, Rare Disease, Diagnostic Strategy, Translational Science, Strategic Science, Product Development, Newborn Screening, Medical Science, Program Management, Scientific Partnership, and Scientific Communication.

Highlights

Apr 24 · linkedin

Robert Califf at #WODC2024 just referenced this recent CDRH announcement on platform based approval pathway for digital health

Aug 14 · linkedin

Excellent article on emerging genome based newborn screening efforts. Data sharing between programs will be essential to help all newborns at risk of rare disease- wherever they are born.

N
Add to my network

Location

San Francisco Bay Area